Änderungen von Dokument Pustulosis subcornealis Sneddon-Wilkinson
Zuletzt geändert von Thomas Brinkmeier am 2025/04/25 20:40
<
>
bearbeitet von Thomas Brinkmeier
am 2020/03/30 19:58
am 2020/03/30 19:58
bearbeitet von Thomas Brinkmeier
am 2022/05/29 17:47
am 2022/05/29 17:47
Änderungskommentar:
Es gibt keinen Kommentar für diese Version
Zusammenfassung
Details
- Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf
-
- Author
-
... ... @@ -1,0 +1,1 @@ 1 +XWiki.Dermatologie_Kompendium - Größe
-
... ... @@ -1,0 +1,1 @@ 1 +620.9 KB - Inhalt
- Wikiderm.EntryClass[0]
-
- Eintrag
-
... ... @@ -65,9 +65,48 @@ 65 65 (% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV 66 66 67 67 (% class="Eintrag-2" %) 68 -(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%) , Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa68 +(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%) 69 69 70 +(% class="Ebene-1" %) 71 +(% class="Bullet" %)-(%%) Dermatitis herpetiformis 72 + 73 +(% class="Ebene-1" %) 74 +(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji 75 + 76 +(% class="Ebene-1" %) 77 +(% class="Bullet" %)-(%%) Impetigo contagiosa 78 + 79 +(% class="Ebene-1" %) 80 +(% class="Bullet" %)-(%%) Pemphigus foliaceus 81 + 70 70 (% class="Eintrag-2" %) 83 + 84 + 85 +(% class="Ebene-1" %) 86 +(% class="Bullet" %)-(%%) Psoriasis pustulosa 87 + 88 +(% class="Ebene-1" %) 89 +(% class="Bullet" %)-(%%) Tinea incognito 90 + 91 +(% class="Ebene-2" %) 92 +(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]] 93 + 94 +(% class="Eintrag-2" %) 95 +(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}} 96 + 97 +(% class="Ebene-1" %) 98 +(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]] 99 + 100 +(% class="Ebene-1" %) 101 +(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]] 102 + 103 +(% class="Ebene-1" %) 104 +(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]] 105 + 106 +(% class="Ebene-1" %) 107 +(% class="Bullet" %)-(%%) JAAD Case Rep. 2022 Jan 21;21:185-188. [[http:~~/~~/doi.org/10.1016/j.jdcr.2021.04.039>>url:http://doi.org/10.1016/j.jdcr.2021.04.039]] 108 + 109 +(% class="Eintrag-2" %) 71 71 (% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal 72 72 73 73 (% class="Ebene-2" %) ... ... @@ -74,6 +74,12 @@ 74 74 (% class="Bullet" %)-(%%) Farbstoffe (**[[Antiseptika]]**) 75 75 76 76 (% class="Ebene-2" %) 116 +(% class="Bullet" %)-(%%) Mometasonfuroat 117 + 118 +(% class="Ebene-3" %) 119 +(% class="Feature" %)Lit:(%%) Dermatol Ther. 2021 Nov 27:e15235. [[http:~~/~~/doi.org/10.1111/dth.15235>>url:http://doi.org/10.1111/dth.15235]] 120 + 121 +(% class="Ebene-2" %) 77 77 (% class="Bullet" %)-(%%) Tacalcitol 78 78 79 79 (% class="Ebene-3" %) ... ... @@ -152,7 +152,9 @@ 152 152 (% class="Feature" %)Stoff:(%%) (% class="Bullet" %)-(%%) **[[Infliximab]]** 153 153 154 154 (% class="Ebene-4" %) 200 +{{pharMacro style="Ebene-4"}} 155 155 (% class="Feature" %)Phar:(%%) Remicade^^®^^ 202 +{{/pharMacro}} 156 156 157 157 (% class="Ebene-4" %) 158 158 (% class="Feature" %)Dos:(%%) 5 mg/kg i.v. ... ... @@ -167,4 +167,11 @@ 167 167 (% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich) 168 168 169 169 (% class="Ebene-5" %) 170 -(% class="Feature" %)PT:(%%) CR 217 +(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%) 218 + 219 +(% class="Ebene-2" %) 220 +(% class="Bullet" %)-(%%) Guselkumab 221 + 222 +(% class="Ebene-3" %) 223 +(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]] 224 +